Key Facts about Polynovo's Indian Government Approval

Polynovo Limited (ASX: $PNV) has received approval from the Indian Government for the inclusion of NovoSorb BTM in the Government-e-Marketplace (GeM) portal. This approval grants access to supply BTM across various government hospitals in India, including Defence hospitals, Railways hospitals, ESIC hospitals, and AIIMS hospitals. The company anticipates the first order to be placed within a month. Additionally, Polynovo's sales in private hospitals in India have been experiencing rapid month-on-month growth.

Executive Commentary on Indian Government Approval

Chairman, David Williams expressed optimism about winning additional tenders to expand the reach of NovoSorb BTM to public hospitals. CEO, Swami Raote highlighted the significance of accessing burn patients admitted to public hospitals, emphasizing the potential to enhance the standard of care and improve the quality of life for Indian patients.

Summary of Indian Government Approval and Outlook

Polynovo's approval for NovoSorb BTM in the Indian Government's GeM portal marks a significant milestone, providing access to a wide network of government hospitals in India. The company's participation in government tenders and the positive sales growth in private hospitals indicate a promising outlook for expanding the usage of NovoSorb BTM in the Indian healthcare sector. The Chairman and CEO's positive outlook on winning additional tenders and accessing burn patients in public hospitals reflects the company's ambitions to improve healthcare standards and patient outcomes in India.